Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Conditions:   Stenosis;   RestenosisInterventions:   Device: Covera Vascular Covered Stent;   Device: Percutaneous Transluminal Angioplasty (PTA)Sponsor:   C. R. BardNot yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2016 Category: Research Source Type: clinical trials

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization
Condition:   Chronic Limb IschemiaInterventions:   Drug: Dexamethasone sodium phosphate injection, USP, 4 mg/mL;   Drug: PlaceboSponsor:   Mercator MedSystems, Inc.Not yet recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2015 Category: Research Source Type: clinical trials

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization
Condition:   Chronic Limb IschemiaInterventions:   Drug: Dexamethasone acetate;   Drug: PlaceboSponsor:   Mercator MedSystems, Inc.Not yet recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2015 Category: Research Source Type: clinical trials